EI
FLGT icon

EAM Investors’s Fulgent Genetics FLGT Stock Holding History

EAM Investors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-41,703
Closed -$1.67M – 327
2020
Q3 		$1.67M Buy
41,703
+11,010
+36% +$345K 0.4% 85
2020
Q2 		$491K Sell
30,693
-137,209
-82% -$2.1M 0.11% 250
2020
Q1 		$1.81M Sell
167,902
-28,835
-15% -$402K 0.56% 67
2019
Q4 		$2.54M Buy
196,737
+104,647
+114% +$1.24M 0.56% 52
2019
Q3 		$957K Buy
+92,090
New +$873K 0.25% 178

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

EAM Investors's FLGT Position: Q4 2020 in Review

EAM Investors sold out of Fulgent Genetics (FLGT) in Q4 2020, closing a stake of 41,703 shares — an estimated $1.67M sold.

EAM Investors first reported a position in FLGT in Q3 2019 and held it in 5 quarters. The position peaked at $2.54M in Q4 2019. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2020.

  • EAM Investors reported no remaining Fulgent Genetics position as of Q4 2020 after selling out during the quarter.
  • EAM Investors sold 41,703 Fulgent Genetics shares in Q4 2020, an estimated $1.67M.
  • EAM Investors first reported a position in Fulgent Genetics in Q3 2019 and held it in 5 quarters.
  • EAM Investors's Fulgent Genetics position peaked at $2.54M in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2020.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.